221
Views
28
CrossRef citations to date
0
Altmetric
Original

Use of hematopoietic progenitor cell count on the Sysmex XE-2100 for peripheral blood stem cell harvest monitoring

, , , , , , , , , , & show all
Pages 89-96 | Received 19 Mar 2006, Accepted 27 Jun 2006, Published online: 01 Jul 2009

References

  • Gratwohl A, Passweg J, Baldomero H, Hermans J. Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1998; 22: 227–240
  • Attal M, Harousseau J L, Stoppa A M, Sotto J J, Fuzibet J G, Rossi J F, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 1996; 335: 91–97
  • Messner H A. Human hematopoietic progenitor in bone marrow and peripheral blood. Stem Cells 1998; 16(Suppl 1)93–96
  • To L B, Haylock D N, Simmons P J, Juttner C A. The biology and clinical uses of blood stem cells. Blood 1997; 89: 2233–2258
  • Andre M, Baudoux E, Bron D, Canon J L, D'Hondt V, Fassotte M F, et al. Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies. Transfusion 2003; 43: 50–57
  • Gratama J W, Orfao A, Barnett D, Brando B, Huber A, Janossy G, et al. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry 1998; 34: 128–142
  • Elliott C, Samson D M, Armitage S, Lyttelton M P, McGuigan D, Hargreaves R, et al. When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. J Clin Oncol 1996; 14: 970–973
  • Gratama J W, Sutherland D R, Keeney M, Papa S. Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells. J Biol Regul Homeost Agents 2001; 15: 14–22
  • Chapple P, Prince H M, Quinn M, Bertoncello I, Juneja S, Wolf M, et al. Peripheral blood CD34+ cell count reliably predicts autograft yield. Bone Marrow Transplant 1998; 22: 125–130
  • Linn Y C, Heng K K, Rohimah S, Goh Y T. Peripheral blood progenitor cell mobilization in three groups of subjects: a comparison of leukapheresis yield and timing. J Clin Apheresis 2000; 15: 217–223
  • Lewis I D, Rawling T, Dyson P G, Haylock D N, Juttner C A, To L B. Standardization of the CFU-GM assay using hematopoietic growth factors. J Hematother 1996; 5: 625–630
  • Lumley M A, Burgess R, Billingham L J, McDonald D F, Milligan D W. Colony counting is a major source of variation in CFU-GM results between centres. Br J Haematol 1997; 97: 481–484
  • Mougi H, Shinmyozu K, Osame M. Determining the optimal time for peripheral blood stem cell harvest by detecting immature cells (immature leukocytes and immature reticulocytes) using two newly developed automatic cell analyzers. Int J Hematol 1997; 66: 303–313
  • Wall D A, Oliver D A. Use of the hematopoietic Progenitor Cell parameter on Sysmex SE-9500 as a screening tool for circulating hematopoietic precursors in pediatrics. Infus Ther Transfus Med 2001; 28: 267–270
  • Ishii T, Kawasumi I, Matsumoto H. SE-9000 IMI channel-focusing on the roles and functions of surfactant. Sysmex J Int 1997; 7: 123–128
  • Menendez P, Caballero M D, Prosper F, Del Canizo M C, Perez-Simon J A, Mateos M V, et al. The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen. Transfusion 2002; 42: 1159–1172
  • Moskowitz C H, Stiff P, Gordon M S, McNiece I, Ho A D, Costa J J, et al. Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients – results of a phase I/II trial. Blood 1997; 89: 3136–3147
  • Ford C D, Chan K J, Reilly W F, Petersen F B. An evaluation of predictive factors for CD34+ cell harvest yields from patients mobilized with chemotherapy and growth factors. Transfusion 2003; 43: 622–625
  • Peng L, Gao X, Jiang H, Peng Z, Su J. Laboratory evaluation of the Sysmex SE-9500 automated haematology analyser. Clin Lab Haematol 2001; 23: 237–242
  • Oelschlaegel U, Bornhaeuser M, Thiede C, Ehninger G, Hoelig K. HPC enumeration with the Sysmex XE-2100 can guide further flow cytometric CD34(+) measurements and timing of leukaphereses. Cytotherapy 2003; 5: 414–419
  • Yu J, Leisenring W, Fritschle W, Heimfeld S, Shulman H, Bensinger W I, et al. Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collection. Bone Marrow Transplant 2000; 25: 1157–1164
  • Lee J L, Kim S B, Lee G W, Ryu M H, Kim E K, Kim S, et al. Clinical usefulness of the hematopoietic progenitor cell counts in predicting the optimal timing of peripheral blood stem cell harvest. J Korean Med Sci 2003; 18: 27–35
  • Serke S, Arseniev L, Watts M, Fritsch G, Ingles-Esteve J, Johnsen H E, et al. Imprecision of counting CFU-GM colonies and CD34-expressing cells. Bone Marrow Transplant 1997; 20: 57–61
  • Pollard Y, Watts M J, Grant D, Chavda N, Linch D C, Machin S J. Use of the haemopoietic progenitor cell count of the Sysmex SE-9500 to refine apheresis timing of peripheral blood stem cells. Br J Haematol 1999; 106: 538–544
  • Endoh A, Yagihashi A, Asanuma K, Moriai R, Izawa A, Koyanagi Y, et al. Hematopoietic progenitor cell counts performed by the Sysmex SE-9000 analyzer can guide timing of peripheral blood stem cell harvest. Anticancer Res 2001; 21: 601–604
  • Vogel W, Kopp H G, Kanz L, Einsele H. Correlations between hematopoietic progenitor cell counts as measured by Sysmex and CD34+ cell harvest yields following mobilization with different regimens. J Cancer Res Clin Oncol 2002; 128: 380–384
  • Bonnet D. Haematopoietic stem cells. J Pathol 2002; 197: 430–440
  • Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002; 30: 973–981
  • Dobo I, Robillard N, Pineau D, Genevieve F, Piard N, Rapp M J, et al. Use of pathology-specific peripheral blood CD34 thresholds to predict leukapheresis CD34 content with optimal accuracy: a bicentric analysis of 299 leukaphereses. Ann Hematol 2001; 80: 639–646

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.